{
  "docId": "019de075-e430-7299-a96e-811e562ad763",
  "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
  "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 27,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 20,
  "notes": "The chart uses a split x-axis to show pre-dose baseline and post-dose results. The 8mg dose maintains maximum sleep latency (40 min) for the duration of the test.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/22",
  "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
  "deckJsonHref": "/decks/019de075-e430-7299-a96e-811e562ad763.json",
  "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.8,
        "x": 0.12,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Maintenance of Wakefulness Test (MWT) results for Pre-dose, Placebo, and ALKS 2680 doses (1mg, 3mg, 8mg)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bcf32f16-feb8-4988-9a42-2af2ee0e1598",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.24,
        "y": 0.4
      },
      "kind": "legend",
      "text": "Pre-dose, Placebo, ALKS 2680 1 mg, ALKS 2680 3 mg, ALKS 2680 8 mg",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7c7efed-8d8e-42c9-b1e4-328a0834ee7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "subtitle",
      "text": "NT1: narcolepsy type 1",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f394c61-e445-40b2-80e4-f5f11de830d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "ALKS 2680 Single Dose Time Course Suggests a Therapeutic Dose Between 3 mg and 8 mg in NT1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30ec57c0-dd2a-471d-be40-d336bbab742a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "284ec5b4-dd39-40c1-9235-a2741ada7d00",
      "evidence": "The slide compares the maintenance of wakefulness test results before and after treatment with ALKS 2680.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "1bd88845-f381-4669-ad24-644b72ef2a79",
      "evidence": "The slide explicitly contrasts Day -1 (Baseline) with Day 1 (Post-dose) to demonstrate drug efficacy.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 23,
      "from": 13,
      "beatId": "a2d3f125-9d63-41e7-ad4b-d97f1d4906af",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The preliminary results from a Phase 1 study of ALKS 2680 demonstrate potential for growth",
      "position": 2,
      "confidence": 0.7,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}